comparemela.com

Latest Breaking News On - Medstar heart - Page 5 : comparemela.com

Business News | MedAlliance SELUTION SLR is the First DEB to Receive Coronary De Novo IDE Approval, Its Fourth FDA IDE DEB Approval

Get latest articles and stories on Business at LatestLY. SELUTION SLR™, MedAlliance s novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of coronary de novo lesions. Business News | MedAlliance SELUTION SLR is the First DEB to Receive Coronary De Novo IDE Approval, Its Fourth FDA IDE DEB Approval.

How to lower heart disease and breast cancer risk at the same time

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.